Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvingtrans Regulatory News (AVG)

Share Price Information for Avingtrans (AVG)

Share Price is delayed by 15 minutes
Get Live Data
652.00    12.00 (1.88%)
Bid:
644.00
Ask:
660.00
Spread: 16.00 (2.484%)
Market Cap: £219.22m
AVG Live PriceLast checked at - London Stock Exchange

Intraday Avingtrans Share Chart

Directorate Change

24 Apr 2008 16:35

Avingtrans PLC24 April 2008 Avingtrans Plc ("Avingtrans") Board Changes Avingtrans plc, the designer, manufacturer and supplier of critical componentsand associated services to the medical, industrial and global aerospace sectors,announces the following Board changes. Peter Kenny, 53, currently managing director of the medical and researchdivision has been appointed to the main Board of Avingtrans as an ExecutiveDirector with immediate effect. Roger McDowell, currently non-Executive Chairman, will become acting ChiefExecutive Officer whilst seeking to appoint a new Chief Executive to replaceSteven Lawrence who, as previously announced, will be stepping down at the endof May 2008. Stephen Bruh, Non-Executive Director since June 2002, will retire from the Boardat the end of July 2008. An experienced replacement is being sought. Roger McDowell commented: "I very much welcome Peter to the Board of Directors and since I have becomeChairman I have been very impressed with his operational skills and depth ofknowledge of our business, he will be a strong asset to the Board. "As previously announced Steven Lawrence will be stepping down as CEO on 31stMay 2008. I will become acting CEO until a suitable candidate has beenidentified. We are actively seeking a high calibre replacement. I would like totake this opportunity to thank Steven for all his efforts over the years atAvingtrans. "Stephen Bruh will retire from the Board on 31st July 2008 as a non-ExecutiveDirector and I would also like to thank him for his valuable contribution to theCompany over the past six years." For further enquiries, please contact: Avingtrans Plc tel: 0115-949-9020Roger McDowell / Stephen King KBC Peel Hunt Ltd (Nominated Adviser & Broker) tel: 020-7418-8900Julian Blunt / David Anderson Hansard Group tel: 020-7245-1100Adam Reynolds Further Information The following is a list of the directorships currently held and previously heldin the past 5 years by Peter John Kenny: Current Directorships: Stainless Metalcraft (Chatteris) Limited Crown UK Limited Previous Directorships: None There is no further information required to be disclosed under paragraph (g) ofSchedule 2 of the AIM rules. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
19th May 202610:20 amRNSHolding(s) in Company
14th May 202612:26 pmRNSHolding(s) in Company
12th May 20267:00 amRNSAdaptix receives CE Certification
6th May 20264:28 pmRNSHolding(s) in Company
30th Apr 20262:42 pmRNSHolding(s) in Company
30th Apr 20262:41 pmRNSExercise of Options & TVR
24th Apr 20262:54 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSStrong Nuclear Orders for Avingtrans
26th Mar 20267:00 amRNS-RScientific Magnetics Ships 20th Quantum Magnet
4th Mar 20267:00 amRNSHolding(s) in Company
25th Feb 20267:00 amRNSInterim Results
12th Feb 202611:49 amRNSHolding(s) in Company
6th Feb 202610:24 amRNSHolding(s) in Company
27th Jan 20265:42 pmRNSExercise of Options & TVR
21st Jan 20267:00 amRNSTrading Update and Notice of Results
12th Jan 20265:13 pmRNSIssue of Share Options
12th Jan 20267:00 amRNS-RMedical & Industrial Imaging Division Appointment
8th Dec 20252:34 pmRNSNotification of Major Holdings
27th Nov 20251:59 pmRNSResult of AGM - Board Appointment
14th Nov 20258:38 amRNSExercise of Options & PDMR Dealings
10th Nov 20257:00 amRNSAdaptix receives FDA 510(K) clearance
1st Oct 20254:52 pmRNSExercise of Options & Total Voting Rights
1st Oct 20253:32 pmRNSHolding(s) in Company
29th Sep 20257:00 amRNSAppointment of Medical Division CEO
24th Sep 20257:00 amRNSPreliminary results for the year ended 31 May 2025
11th Sep 20258:00 amRNSHolding(s) in Company
2nd Sep 20257:00 amRNSHayward Tyler Secures $16m Nuclear Contracts
28th Aug 20257:00 amRNSBooth Industries secures £8.5m HS2 & TfL contracts
25th Jun 20257:00 amRNSTrading Update and Notice of Results
28th May 20257:00 amRNSTrading Update
26th Feb 20257:00 amRNSInterim Results
13th Feb 20257:00 amRNSBooth Industries secures £4.5m Contract
16th Jan 20257:00 amRNSTrading Update & Notice of Results
21st Nov 20244:09 pmRNSResult of AGM
24th Oct 20249:07 amRNSHolding(s) in Company
25th Sep 20247:00 amRNSPreliminary results for the year ended 31 May 2024
3rd Jul 20247:00 amRNSPDMR Dealings
19th Jun 20247:00 amRNSTrading Update and Notice of Results
26th Mar 202411:15 amRNSPDMR Dealings
21st Mar 20245:15 pmRNSExercise of Options, PDMR Dealings & TVR
20th Mar 20243:39 pmRNSHolding(s) in Company
4th Mar 20246:10 pmRNSPDMR Dealings
28th Feb 20247:00 amRNSInterim Results
18th Jan 20247:00 amRNSTrading Update and Notice of Results
15th Dec 20233:00 pmRNSExercise of Options & TVR
4th Dec 20237:00 amRNSMagnetica Limited appoints US distributor
22nd Nov 20237:00 amRNSEmployee & PDMR Share Incentive Awards
16th Nov 20232:20 pmRNSResult of AGM
13th Nov 20237:00 amRNSHayward Tyler Contract Win
11th Oct 20237:00 amRNSContract Wins

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.